Article Details
Retrieved on: 2022-04-14 12:25:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
CMS' investment in Trinomab in 2021 is its first deal made in the business model of industrial investment in domestic biotech companies.
Article found on: www.prnewswire.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here